A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Boehringer Ingelheim
Boehringer Ingelheim
Agenus Inc.
University of California, San Diego
Ann & Robert H Lurie Children's Hospital of Chicago
University of Wisconsin, Madison
Novartis
Novartis
The First Affiliated Hospital of Guangzhou Medical University
Novartis
Chinese PLA General Hospital
Novartis
Novartis
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
iTeos Therapeutics
University of Pittsburgh
HRYZ Biotech Co.
University Health Network, Toronto
TriSalus Life Sciences, Inc.
Novartis
Dana-Farber Cancer Institute
Pfizer
Novartis
Novartis
Novartis
Pancreatic Cancer Action Network